-Onconic Therapeutics recibe la aprobación del MFDS para JAQBO, un nuevo tratamiento para la enfermedad por reflujo gastroesofágico (GERD) SEUL, Corea del Sur, 25 de abril de 2024 /PRNewswire/ — Onconic Therapeutics, una empresa de biotecnología líder en Corea, anunció hoy que el…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.